Variability in clinical triggers for organ donation referrals

Kylie Casey1, Elizabeth Thomas2

  • 1Baptist Health System, San Antonio, TX, United States.

Insights

Donor hospitals lack standardized clinical triggers for referring potential organ donors to Organ Procurement Organizations (OPOs). This inconsistency delays referrals and reduces organ availability, highlighting a critical bottleneck in the organ donation process.

Area of Science:

  • Organ transplantation
  • Medical regulation
  • Public health

Background:

  • Regulatory efforts in organ transplantation primarily focus on Organ Procurement Organizations (OPOs) and transplant centers.
  • Donor hospitals, the initial point of contact for potential donors, are under-examined despite their crucial role.
  • Lack of standardized criteria in donor hospitals leads to variability in patient referral to OPOs, potentially delaying organ donation and reducing organ availability.

Purpose of the Study:

  • To examine the clinical triggers used by donor hospitals for referring potential organ donors to OPOs.
  • To identify inconsistencies in clinical trigger criteria across different OPOs.
  • To propose standardization of clinical triggers to improve the organ donation process.

Main Methods:

  • Analysis of clinical triggers from 55 of 56 U.S. Organ Procurement Organizations (OPOs).
  • Evaluation of criteria such as Glasgow Coma Scale thresholds, brainstem reflexes, family discussion protocols, and notification windows.

Main Results:

  • Marked inconsistency found in clinical triggers used by U.S. OPOs.
  • Glasgow Coma Scale thresholds were used by 69.1% and brainstem reflexes by 54.6%, with significant variation.
  • Notification windows varied widely, from immediate to 240 minutes, and fewer than half of OPOs addressed family discussions.

Conclusions:

  • Discrepancies in clinical triggers represent a critical bottleneck in donor identification.
  • Standardizing clinical triggers and implementing performance metrics can enhance early donor identification and organ recovery.
  • Improving donor hospital practices is essential for optimizing the organ transplant system and reducing waitlist mortality.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
682
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
165
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
86.1K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279